OncoDaily Pulse

Aug 31, 2025, 15:58

Paul A. Merguerian: Meet the Experts of VIRO 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.

The congress is free to attend.
Register via the link.

Co-Chair of VIRO

Images Name

Rana McKay
Professor of Medicine and Urology at UC San Diego Health Co-leader of the GU Oncology Program at Moores Cancer Center

As Co-Chair of VIRO, Dr. Rana McKay (University of California, San Diego) opened the congress with her talk on
“Future Directions: Emerging Agents and Combinations.”

She emphasized the momentum in renal cell carcinoma (RCC) research, highlighting how novel immunotherapies, targeted drugs, and rational combination strategies are reshaping patient care. Dr. McKay underscored the importance of personalized, biomarker-driven approaches and global collaboration, aiming to optimize survival and quality of life worldwide.

Spotlight on Paul A. Merguerian

Dr. Paul A. Merguerian is the Division Chief of Pediatric Urology at Seattle Children’s Hospital and a Professor of Urology at the University of Washington.

At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Dr. Merguerian will present on “Surgical Management of Renal Tumors in Children and Young Adults.” His presentation will cover:

Surgical techniques and approaches tailored to pediatric and young adult patients.
Challenges unique to managing renal tumors in younger populations.
Advances in minimally invasive and reconstructive surgery improving outcomes.
Strategies to optimize long-term kidney function and quality of life post-surgery.

Drawing on extensive clinical experience and academic leadership, Dr. Merguerian focuses on delivering precise, patient-centered surgical care that addresses the complex needs of pediatric renal tumor patients.

Global Voices in Renal Oncology (VIRO) 2025